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BACKGROUND AND PURPOSE
Interest in non-selective cation channels has increased recently following the discovery of transient receptor potential (TRP)
proteins, which constitute many of these channels.
EXPERIMENTAL APPROACH
We used the whole-cell patch-clamp technique on isolated ventricular myocytes to investigate the effect of flufenamic acid
(FFA) and related drugs on membrane ion currents.
KEY RESULTS
With voltage-dependent and other ion channels inhibited, cells that were exposed to FFA, N-(p-amylcinnamoyl)anthranilic
acid (ACA), ONO-RS-082 or niflumic acid (NFA) responded with an increase in currents. The induced current reversed at
+38 mV, was unaffected by lowering extracellular Cl- concentration or by the removal of extracellular Ca2+ and Mg2+, and its
inward but not outward component was suppressed in Na+-free extracellular conditions. The current was suppressed by Gd3+
but was resistant to 2-aminoethoxydiphenyl borate (2-APB) and to amiloride. It could not be induced by the structurally
related non-fenamate anti-inflammatory drug diclofenac, nor by the phospholipase-A2 inhibitors bromoenol lactone and
bromophenacyl bromide. Muscarinic or a-adrenoceptor activation or application of diacylglycerol failed to induce or
modulate the current.
CONCLUSIONS AND IMPLICATIONS
Flufenamic acid and related drugs activate a novel channel conductance, where Na+ is likely to be the major charge carrier.
The identity of the channel remains unclear, but it is unlikely to be due to Ca2+-activated (e.g. TRPM4/5), Mg2+-sensitive (e.g.
TRPM7) or divalent cation-selective TRPs.
Abbreviations
2-APB, aminoethoxydiphenylborate; ACA, N-(p-amylcinnamoyl)anthranilic acid; APD, action potential duration; BEL,
bromoenol lactone; BPB, bromophenacyl bromide; CCh, carbachol; DAG, diacylglycerol; Erev, reversal potential; FFA,
flufenamic acid; HCN, hyperpolarization-activated channel; NALCN, sodium leak channel; NFA, niflumic acid; NMDG,
N-methyl-D-glucamine; OAG, 1-oleoyl-2-acetyl-sn-glycerol; PE, phenylephrine; PLA2, phospholipase A2; TEA,
tetraethylammonium; TRP, transient receptor potential; TRPA, transient receptor potential, ankyrin; TRPC, transient
receptor potential, canonical; TRPM, transient receptor potential, melastatin; TRPP, transient receptor potential,
polycystin
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Introduction
Besides the classic selective ion channels, non-
selective ion channels are expressed in many cells
and may play important roles in normal cellular
physiology and in pathology. In cardiac cells, the
best known non-selective ion channels are the If or
HCN channels, which conduct Na+ and K+ and play
a major role in determining pacemaker activity
(DiFrancesco, 1986), and the Ca2+-activated chan-
nels (Colquhoun et al., 1981; Ehara et al., 1988).
Additional non-selective channels are present (see
Discussion) but, generally, most such channels have
remained difficult to identify using electrophysi-
ological techniques not only in cardiac but also in
other cell types. This is due to technical difficulties
in distinguishing currents carried by non-selective
channels from leak flows via non-channel pathways
such as the seal between recording pipette and cell
membrane, and to problems in separating currents
carried by different non-selective channels co-
expressed in the same cell, as specific inhibitors are
still lacking. The identification of non-selective
channels remains nevertheless important given
their potential roles and the possibility that they
may constitute targets for therapeutic agents. In
recent years, interest in non-selective channels has
increased significantly following the discovery of
transient receptor potential (TRP) proteins, of which
many have been shown to underlie various such
channels in different types of cells (Clapham, 2003;
Nilius, 2007).
In cardiac cells, molecular biology and immun-
ostaining methods have demonstrated the expres-
sion of a variety of TRP channels, including those of
the canonical (TRPC), melastatin (TRPM) and poly-
cystin (TRPP) subfamilies (channel nomenclature
follows Alexander et al., 2009). Only TRPC1 (Seth
et al., 2009), TRPC3 (Onohara et al., 2006), a few
TRPM (TRPM4, TRPM5, TRPM7) (Guinamard et al.,
2004; 2006a,b; Gwanyanya et al., 2004) and puta-
tive TRPP channels (Volk et al., 2003), have been
characterized electrophysiologically in the heart.
The cardiac TRP channels thus far identified have
been reported to be implicated in such diverse
processes as pacemaking (Demion et al., 2007;
Guinamard and Bois, 2007), Mg2+ transport (Gwan-
yanya et al., 2004), myocardial hypertrophy (Kuwa-
hara et al., 2006; Onohara et al., 2006; Guinamard
and Bois, 2007; Shan et al., 2008; Watanabe et al.,
2008; Seth et al., 2009; Watanabe et al., 2009),
arrhythmogenesis (Guinamard and Bois, 2007;
Alvarez et al., 2008) and response to stretch
(Dyachenko et al., 2009). Despite this now well-
recognized importance of TRPs it remains possible
that other, non-TRP proteins may underlie some
cation non-selective channels. Molecular biology
techniques have been used successfully to study ion
channels, but when such tools cannot be utilized to
identify, separate or modulate ion channels because
the underlying proteins are not known, a combina-
tion of electrophysiology and pharmacological tools
remains a powerful experimental approach.
Flufenamic acid (FFA) and other fenamates
are phenylaminobenzoic (or phenylanthranilic)
acid derivatives generally known for their anti-
inflammatory and ion channel-blocking properties.
The anti-inflammatory action is due to the inhibi-
tion of cyclo-oxygenase, that is, to the suppression
of prostaglandin synthesis from arachidonic acid.
The blocking action of fenamates is exerted on a
variety of channels, including Cl- channels, voltage-
dependent Na+ or Ca2+ channels and TRP channels
(Kraft and Harteneck, 2005). They also inhibit other
non-channel transporters, for example, the Na+-
dicarboxylate transporter (Pajor and Randolph,
2007). Similar inhibitory actions have been reported
for the related cinnamoyl-anthranilic derivatives
(Harteneck et al., 2007). In contrast to these inhibi-
tory effects, stimulatory actions of fenamates on
channels have also been increasingly reported.
Examples include a stimulation of Ca2+-activated
large conductance K+ (or maxi KCa) channels (Liu
et al., 2005) and the activation by FFA of some TRP
channels, such as TRPC6 (Jung et al., 2002; Foster
et al., 2009) or TRPA1 (Hu et al., 2010). In our
attempts to test for a blocking effect of FFA and
related drugs on TRPM7 channel currents in cardiac
myocytes, we discovered that they induce a current
with novel characteristics, different from those of
other, well-characterized, channels.
Methods
All animal care and experimental procedures in this
study were according to the institutional guidelines
for laboratory animal care and approved by the
Ethical Commission on Animal Experiments of the
University of Leuven.
Cell isolation and electrophysiological
techniques
We used left ventricular myocytes dissociated from
pig and sheep hearts by enzymatic digestion during
Langendorff perfusion at 36°C, as described in detail
before (Macianskiene et al., 2002; Gwanyanya et al.,
2004; 2006). Experiments were performed either at
room temperature (22–23°C; for ion current mea-
surements) or at 36–37°C (for action potential
recordings). Voltage clamp experiments testing bro-
moenol lactone (BEL) effects were also carried out at
36°C (Smani et al., 2003).
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The pClamp 8.1 software was used to generate
stimuli protocols and to record data via a Digidata
1322A acquisition system (Axon instruments,
Union City, CA, USA). The voltage clamp protocols
usually consisted of 4 s symmetrical ramps from
-120 mV to +80 mV and back to -120 mV, applied
every 10 s. During the ascending limb of the ramp,
the slow rate of depolarization (0.1 V·s-1) allowed
activation and inactivation of the voltage-
dependent Na+ current. The currents of interest were
measured during the descending limb of the voltage
ramp. In a few experiments, 600 ms voltage steps
were also given to various potentials from a holding
of -40 mV. In most experiments currents through
L-type Ca2+ (CaV1.2) or via rapid delayed rectifier K+
(KV11.1 or IKr) channels were blocked by nifedipine
(10 mM) and E-4031 (5 mM) respectively. Action
potentials were elicited under current clamp in
ruptured or perforated patch recording modes.
The stimulus consisted of 2 ms rectangular current
pulse applied at 1 Hz via the patch electrode.
Action potential durations were measured at 90%
repolarization (APD90).
Solutions
The composition of the standard Tyrode solution
used during cell isolation and during action poten-
tial measurements was (in mM): 135 NaCl, 5.4 KCl,
1.8 CaCl2, 0.9 MgCl2, 0.33 NaH2PO4, 10 HEPES (pH
7.4, adjusted with NaOH) and 10 glucose. The solu-
tion was bubbled with 100% O2 during cell dissocia-
tion. During ion current measurements, cells were
superfused with a solution of similar composition
except that K+ was replaced by Cs+. When desired,
divalent cations were omitted or N-methyl-D-
glucamine (NMDG) used to replace Na+. The stan-
dard pipette solution contained (in mM): 130 Cs
glutamate, 25 CsCl or tetraethyl ammonium chlo-
ride (TEA Cl), 5 Na2ATP, 5.5 MgCl2 (0.8 mM free
Mg2+), 1 EGTA, 0.1 Na2GTP, 5 HEPES (pH 7.25;
adjusted with CsOH). This internal solution was
modified in a few experiments, to increase Ca2+ buff-
ering (1 EGTA replaced by 10 EDTA), to remove Na+
(5.5 MgCl2 and 5 Na2ATP replaced by 5.5 MgATP) or
to increase free intracellular Mg2+ to 4.6 mM (10
MgCl2 and 5.5 MgATP). The pipette solution for
current clamp measurements was similar to the
above standard internal solution, with Cs+ replaced
by K+. For perforated patch recordings, 325 mM
amphotericin B and 1.8 mM CaCl2 (to cause cell
death in case of patch rupture) were added to this
pipette solution.
Data and statistical analyses
Data were analysed using Clampfit 8.2 (Axon Instru-
ments) and Origin 7 (Microcal, Northampton, MA,
USA). The following Hill equation was used to fit the
drug (D) effects as a function of concentration:
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where ID is the current induced at a given drug
concentration [D], Imax the maximum drug-induced
current, K0.5 the drug concentration for 50% effect
and nHill the Hill coefficient. Average data are
expressed as mean  standard error of the mean,
with n indicating the number of cells studied.
Means were compared using the two-tailed t-test, or
ANOVA followed by Bonferroni’s post-test. P  0.05
was taken as threshold for statistical significance.
Materials
The chemical structures of FFA and related drugs
tested in the present study are displayed in
Figure 1. FFA and diclofenac were obtained
from Sigma-Aldrich (Bornem, Belgium), whereas
N-(p-amylcinnamoyl)anthranilic acid (ACA) and
2-(p-amylcinnamoyl)amino-4-chlorobenzoic acid
Figure 1
Chemical structures of flufenamic acid and related drugs. Flufenamic
(2-{[3-(trifluoromethyl)phenyl]amino}benzoic) acid is a typical
fenamate, containing a phenyl ring attached, via an amino group, to
benzoic acid (the aminobenzoic acid group is also called anthranilic
acid). ACA (N-(p-amylcinnamoyl)anthranilic acid and ONO-RS-082
(2-(p-amylcinnamoyl)amino-4-chloro benzoic acid) contain the ami-
nobenzoic acid moiety but with a cinnamoyl, instead of a phenyl
group attached to the amino group. The two drugs differ by the
substituents (H vs. Cl) in position 4 of the benzoic moiety. Diclofenac
(2-[2-(2,6-dichlorophenyl)aminophenyl]acetic acid) differs fromflufe-
namic acid by having a phenylacetyl instead of the benzoyl (phenyl-
carboxyl) group, and by the substitutions in the second phenyl group.
Niflumic acid (2-{[3-(trifluoromethyl)phenyl]amino}nicotinic acid) is
similar to flufenamic acid but its benzoic group is replaced by a
nicotinic group.
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(ONO-RS-082) were from Biomol (Tebu-Bio,
Boechout, Belgium; or Enzo Life Sciences, Zand-
hoven, Belgium). Oleoyl-acetyl-glycerol (OAG) and
nifedipine were also from Biomol. All other drugs or
chemicals were from Sigma-Aldrich or Merck (Darm-
stadt, Germany). FFA, ACA, diclofenac, BEL and bro-
mophenacyl bromide were prepared as stock
solutions in DMSO. Nifedipine was prepared in
ethanol. Other chemicals were dissolved in water.
Results
Induction of a current by the fenamate FFA
and by related compounds
Experiments were carried out on myocytes intracel-
lularly dialysed with solutions containing Mg2+ (0.8–
4.6 mM free ion concentration) to prevent the
activation of the TRPM7 current (Zakharov et al.,
2003; Gwanyanya et al., 2004; Demeuse et al.,
2006). Under such conditions, baseline currents
remained stable over time, that is, there was no
increase of outward current with time, in contrast to
what is observed when dialysing cells with low-Mg2+
or Mg2+-free solutions (Zakharov et al., 2003). The
effect of applying the fenamate, FFA or the related
compound ACA, on such cells is illustrated in
Figure 2. In Figure 2A membrane current tracings
obtained using a voltage ramp between -120 mV
and +80 mV in control conditions, during applica-
tion of 100 mM FFA and after drug washout are dis-
played. The drug caused an inward shift of the
current–voltage relation at potentials below +38 mV
and an outward shift at more positive potentials.
The time evolution of inward currents measured at
-120 mV and of outward currents measured at
+80 mV in the same cell is illustrated in Figure 2B.
Currents were stable before drug application but
progressively increased during treatment with FFA.
Figure 2C displays tracings obtained in another cell
in control conditions, during application of 50 mM
ACA and after drug washout, whereas Figure 2D
shows the corresponding time evolution of currents
measured at -120 mV and +80 mV during two
repetitive ACA applications. The effects of ACA were
qualitatively similar to those of FFA: inward current
Figure 2
Flufenamic acid (FFA)- and N-(p-amylcinnamoyl)anthranilic acid (ACA)-induced current in ventricular myocytes. A, C: Effects of extracellular
application of FFA (100 mM; A) or ACA (50 mM; C) on whole-cell membrane currents. Traces of current–voltage relationships obtained using
voltage ramps from +80 mV to -120 mV, under control extracellular conditions (), in the presence of either drug () and after drug washout
(). B, D: Time course of whole-cell currents measured at +80 mV and -120 mV in the same cells as in A and C respectively. The period of
superfusion with drug is indicated by horizontal bar.
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shift at potentials below +36 mV and outward shift
at more positive potentials. The drug-induced
current (not illustrated), defined as the difference
current obtained by subtracting the tracing in basal
conditions from the one in the presence of the drug,
showed a reversal potential (Erev) of +38  2.8 mV
(n = 9) for FFA and +38  1.2 mV (n = 32) for ACA.
The effects of FFA or ACA developed progres-
sively with time and reached steady state usually
over several (>5) minutes. The effects of FFA were
readily reversible upon drug washout (Figure 2B), as
were those following short exposures of ACA
(Figure 2D). In six cells where sufficient washout
could be carried out following 30–50 mM ACA appli-
cation, the currents induced at -120 mV was -0.5 
0.14 pA/pF when measured relative to baseline cur-
rents (before drug application), and -0.4 
0.11 pA/pF relative to the post drug washout level.
There was no statistically significant difference
between these induced currents (P = 0.45; t-test),
indicating a near-complete reversibility of the drug
effects in these cells, and that, under these condi-
tions, leak currents had minimal effects on the drug-
induced current. After washout, the initial effect was
reproducible upon repeated drug application (see
Figure 2D). However, ACA effects were difficult to
wash out following prolonged exposure or high
(>50 mM) concentrations (see Figure 3E).
We also tested the effects of the following related
drugs: (i) ONO-RS-082, which, except for a Cl
attached to the benzoic ring, is structurally identical
to ACA (see Figure 1) and, like ACA, is known to
inhibit secretory phospholipase A2 (PLA2) (Konrad
et al., 1992); (ii) niflumic acid (NFA), which, like FFA
contains a trifluoro-phenyl group but with the
benzoic group replaced by a nicotinic group; and
(iii) the anti-inflammatory drug diclofenac, in
which the phenyl-carboxyl forming the aminoben-
zoic moiety has been replaced by a phenyl-acetyl
(see Figure 1). Like ACA, ONO-RS-082 was able to
increase membrane currents (Erev = +38  4.4 mV,
n = 3), but a concentration of at least 100 mM was
needed for the effect (Figure 3A and 3B). Similarly
NFA induced a small current (n = 4) at 300 mM
(Figure 3C and 3D). In contrast, diclofenac at
100 mM (n = 6) or 300 mM (n = 4; inward current
increase of -0.03  0.02 pA/pF at -120 mV) was
unable to induce any significant current change,
even under conditions where FFA and ACA could be
shown to be effective (Figure 3E and 3F). The drug
also did not appear to act as an antagonist towards
the other drugs as its prior application at 300 mM did
not prevent the effect of 100 mM FFA applied in
addition (Figure 3F).
All cells that were challenged either with FFA
(100 mM), ACA (3 mM) or ONO-RS-082
(100 mM) responded with an increase in currents.
Only two out of four cells responded to 300 mM
NFA. The effects were concentration-dependent.
The concentration-effect curve for ACA showed a
half-maximum effective concentration (K0.5) of
24 mM, with a Hill coefficient of 1.5 (Figure 4, n =
3–23), and the relative change (ID/Imax) was similar
for induced inward and outward currents (not illus-
trated). At -120 mV, the drug-induced current in pig
cells was -0.4  0.04 pA/pF for 30 mM ACA (n = 23),
-0.7  0.13 pA/pF for 300 mM FFA (n = 4), -0.3 
0.10 pA/pF for 100 mM ONO-RS-082 (n = 3) and -0.3
 0.07 pA/pF for 300 mM NFA (n = 4). ACA, which
appeared to be the most potent of all drugs tested,
was used for most subsequent experiments.
Whereas the above and subsequent data describe
the results obtained in pig cells, similar effects could
be obtained in sheep ventricular and atrial myo-
cytes. Figure 5 shows an example from a sheep left
ventricular myocyte, and further illustrates that the
ACA-induced current was time-independent during
a voltage step.
Na+ as charge carrier of the inward current
The magnitude of the ACA-induced current or its
Erev were not changed upon lowering extracellular
Cl- concentrations by substituting the anion with
methylsulfate (not illustrated). Given our experi-
mental conditions, where Na+ is the ion with equi-
librium potential (ENa: +67 mV) closest to the above
Erev values, it is very likely that Na+ carries the
current induced by ACA. Alternatively, a combina-
tion of divalent and monovalent cations could be
involved. We therefore tested the effect of ACA in
cells superfused with Na+-free solutions. In the
absence of extracellular Na+, the inward component
but not the outward component of the ACA-
induced current was markedly decreased (Figure 6A
and 6B) and could be restored with Na+
re-admission (Figure 6A and 6C; see also Figure 2D
and summary data in Figure 6F). In addition,
during drug application the inward current in the
absence of extracellular Na+ and Ca2+ was not modi-
fied by re-admitting 1.8 mM Ca2+ (Figure 6D). Simi-
larly, the ACA effect in the presence of extracellular
Na+ was not modified by removing external both
Ca2+ and Mg2+ (n = 3, not illustrated). Inward
current could still be induced in the absence of
extracellular Na+, Ca2+ and Mg2+ (n = 6, Figure 6F),
indicating permeability to either Cs+ or NMDG+.
These results suggest that the inward component of
the ACA-induced current was largely carried by Na+
with no or little contribution of the divalent
cations at their physiological concentrations. The
outward component of the ACA-induced current
could be due to intracellular Na+ or Cs+. In cells
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dialysed with Na+-free intracellular solutions (n =
4), outward currents could still be induced by ACA
(Figure 6E), making it likely that it was carried by
Cs+, the only remaining major intracellular cation
under our experimental conditions. We noticed
that the outward component of the ACA-induced
current was very small or absent in cells where
25 mM TEA-Cl was included in the pipette solu-
tion, suggesting an apparent block by internal
TEA+, but this was not further investigated.
Failure of diacylglycerol to activate
the current
Fenamates have been shown to potentiate
a-adrenoceptor-mediated induction of a cation
current in smooth muscle (Yamada et al., 1996). In
Figure 3
Effect of ONO-RS-082 and niflumic acid (NFA), but lack of effect of diclofenac in inducing current in ventricular myocytes. A, C: Traces of
current–voltage relationships obtained using voltage ramps from +80 mV to -120 mV, under control extracellular conditions () and in the
presence of either drug (): 100 mM ONO-RS-082 (A) or 300 mM NFA (C) respectively. B, D: Time course of whole-cell currents measured at
+80 mV and -120 mV in the same cell as in A and C respectively. The period of superfusion with drugs is indicated by horizontal bar. E, F: Failure
of diclofenac to increase currents or to prevent the effect of flufenamic acid (FFA). ACA, N-(p-amylcinnamoyl)anthranilic acid.
BJPNovel cation current in cardiac ventricular cells
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this preparation, the fenamate-induced currents are
carried by divalent cations and are likely to be due
to the activation of TRPC6 channels by diacylglyc-
erol (DAG) (Jung et al., 2002). Despite the difference
in charge carrier compared with the currents
described here in cardiac cells, we examined the
possibility that DAG-sensitive channels underlie the
ACA-induced current in our preparation. On testing
whether exogenous application of the DAG ana-
logue 1-oleoyl-2-acetyl-sn-glycerol (OAG) could
produce effects like those of ACA, we found that
100 mM OAG failed to induce any current, in four
cells (Figure 7A). In addition, we examined whether
endogenous DAG putatively released upon receptor
activation by muscarinic and adrenoceptor agonists
could enhance the current induced by ACA. No
effect was obtained in seven cells with carbachol
(100 mM) or phenylephrine (40 mM) given either
separately or together in addition to ACA
(Figure 7B).
As various aminobenzoic derivatives, including
ACA and ONO-RS-082, inhibit PLA2, we also exam-
ined whether their effect could eventually be due to
the modification of some tonic action of PLA2
catalysis products. We therefore tested the effect of
two other but chemically unrelated PLA2 inhibitors.
Figure 7C and 7D show that neither the selective
inhibitor of Ca2+-independent PLA2, BEL (also
known as haloenol lactone suicide substrate or
HELSS; 25 mM; n = 5) nor the non-specific PLA2
inhibitor bromophenacyl bromide (50 mM; n = 5)
had any effect on membrane currents. These data
exclude a mechanism operating via PLA2 as the basis
for the change in membrane currents by ACA.
No influence of intracellular Ca2+-buffering.
Modulation by ion channel blockers
Highly buffering intracellular Ca2+ and Mg2+ (10 mM
EDTA, n = 9) did not prevent ACA from inducing an
inward current on top of the TRPM7 current present
under these conditions (not illustrated). Finally, the
current induced by ACA was completely blocked
by 100 mM Gd3+ (n = 3), but was found to be insen-
sitive to 50–100 mM 2-aminoethoxydiphenyl borate
(2-APB; n = 3) and 10 mM amiloride (n = 4) (not
illustrated).
In preliminary experiments examining whether
the ACA effect was modified by pH, lowering pH to
6.6 did not decrease, but was rather associated with
an increase of the ACA-induced current compared
with the effect at normal pH (ACA-induced current
at -120 mV: -0.78  0.24 pA/pF at pH 6.6 vs. -0.34
 0.12 pA/pF at pH 7.4 in the same cells; P = 0.11;
paired t-test; n = 3). No current change was obtained
in the absence of ACA (n = 4).
Effect on action potential
An isolated effect of ACA, FFA and related drugs on
membrane potentials, due to the induced current
described above, is difficult to investigate because
the drugs affect other ion channels that normally
contribute to the action potential, including
voltage-dependent channels, Ca2+-activated Cl- cur-
rents and delayed rectifier K+ currents (see Introduc-
tion). Figure 8A shows that a prominent effect of
ACA was a decrease in the peak amplitude of the
action potential, measured under ruptured-patch
conditions, due to a lowering of the overshoot
potential, an effect likely due to a block of voltage-
dependent Na+ channels (our unpublished results).
At low (30 mM) ACA concentration, this effect
occurred without a depolarization of the resting
potential and was associated with a decrease of the
action potential duration. As the ACA concentration
was increased (30 mM), there was a further
decrease in the overshoot potential, and in addition
the resting membrane was depolarized and the
action potential lengthened relative to its duration
with lower concentrations (Figure 8A; see summary
data in Figure 8B and 8C). In some cells, this later
lengthening could bring the action potential to a
longer duration compared with control. Because
diclofenac was unable to induce the novel current
while sharing with ACA the effects on many other
channels underlying the action potential (our
unpublished data), its effects served as reference
for comparison with those of ACA. Like ACA,
Figure 4
Concentration dependence of the effect of N-(p-
amylcinnamoyl)anthranilic acid (ACA). Pooled data (n = 3–23) on the
effects of different concentrations of the drugs tested. Data points for
ACA are fitted by the Hill equation (see Methods), with Vmax =
-0.50 pA/pF, K0.5 = 24 mM; and nHill = 1.5 (continuous curve). Data for
the other drugs were not fitted because only two concentrations of
each were tested. FFA, flufenamic acid; NFA, niflumic acid.
BJP R Macianskiene et al.
422 British Journal of Pharmacology (2010) 161 416–429
diclofenac decreased the overshoot potential and
the total duration of the action potential
(Figure 8D). However, in contrast to ACA, the drug
was unable to cause the secondary action potential
lengthening (Figure 8D; see summary data in
Figure 8E) or depolarize the cells (Figure 8D; see
Figure 8F). Similar results were obtained when
applying the drugs while measuring under
perforated-patch conditions (not illustrated). These
results indicate that the latter two effects can, to
some extent, be attributable to the novel current
induced by ACA.
Discussion
Non-selective cation channels in cardiac cells
A large variety of non-selective cation channels have
been detected in cardiac cells (e.g. Colquhoun et al.,
1981; Matsumoto and Pappano, 1989; Kim and Fu,
1993; Ruknudin et al., 1993; Tarr et al., 1994; Parker
and Scarpa, 1995; Zhang and Hancox, 2003; Gwan-
yanya et al., 2004; 2006; Guinamard et al., 2006a;
Youm et al., 2006). One important issue concerning
these channels is to identify the underlying pro-
teins. For some of them, the underlying proteins are
now known: HCN proteins for the pacemaker
channel (Moroni et al., 2001; Robinson and
Siegelbaum, 2003), TRPM4 or TRPM5 proteins
for the Ca2+-activated Na+-conducting channels
(Guinamard et al., 2006b; Guinamard and Bois,
2007) and connexins for the gap junction channels
(John et al., 1999; Kondo et al., 2000). Recent data
suggest that TRP proteins may also underlie many of
the heretofore unidentified non-selective cation
channels. For example, cardiac stretch-activated
channels are proposed to be formed by TRPC1
(Maroto et al., 2005; Watanabe et al., 2008;
Figure 5
N-(p-amylcinnamoyl)anthranilic acid (ACA)-induced current in sheep ventricular myocytes. A: Traces of currents obtained using voltage steps
between -100 mV and +70 mV, with 10 mV increments (but displayed with 20 mV increments), under control conditions (left), in the presence
of 30 mM ACA (middle), and following drug washout (right). B: Current–voltage relationships obtained using end-of-pulse currents in A: under
control conditions (), in the presence of ACA () and after drug washout (). C: Time course of currents at +80 mV and -120 mV obtained using
voltage ramps in the same cell as in the other panels. The period of superfusion with ACA is indicated by horizontal bar.
BJPNovel cation current in cardiac ventricular cells
British Journal of Pharmacology (2010) 161 416–429 423
Dyachenko et al., 2009), purinergic receptor-
activated channels by TRPC6 (Alvarez et al., 2008)
and the cardiac Mg2+-sensitive, PIP2-dependent
channel by TRPM7 (Gwanyanya et al., 2006).
However, for many other channels, the constituent
proteins remain unknown.
The other issue concerns the role of the various
non-selective channels. Except for an involvement
of If (HCN) and eventually Ca2+-activated TRPM4/5
channels (Demion et al., 2007) in pacemaking, the
other channels are supposed to induce electro-
physiological or ion concentration changes associ-
ated with pathophysiological processes such as
arrhythmogenesis, myocardial hypertrophy or
heart failure.
Novel channel activated by FFA and
related drugs
In the present study we describe a current, induced
by FFA, ACA and related drugs, that displays various
characteristics, of which some are in many respects
similar to those of already known channels, while
others are different. One first and major character-
istic is the activation by FFA that distinguishes it
from other cation channels, generally inhibited by
fenamates. Other exceptions to this inhibition by
fenamates are HCN channels, purinergic receptor-
activated channels and insulin-activated channels.
The second major characteristic of the conductance
pathway identified in the present study is its perme-
Figure 6
Cation permeability of the N-(p-amylcinnamoyl)anthranilic acid (ACA)-induced conductance. A, B, C: Effects of ACA (30 mM) during superfusion
with Na+-free (Na+o replaced by NMDG+o) or Na+-containing extracellular solutions. Data from one same single cell. A: Time course of current at
+80 mV and -120 mV. B, C: Current–voltage relationships under basal condition (), in the presence of ACA () and after drug washout (),
during superfusion with Na+-free extracellular solution (B) or during superfusion with standard (Na+-containing) extracellular solution (C). D:
Failure of Ca2+ to increase inward current in the presence of ACA (30 mM) in a cell superfused with Na+-free extracellular solution. E: Failure of
removal of intracellular Na+ to suppress the outward current induced by ACA (30 mM) at positive potentials. F: Pooled data of ACA-induced
currents measured at -120 mV in the presence of different types of extracellular solutions. **P < 0.01 versus control; ANOVA with post hoc test.
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ability profile. The pathway displays high perme-
ability to Na+ (PNa), as indicated by the value of the
reversal potential (Erev), close to ENa, and by the large
suppression of the inward component of the
induced-current following substitution of external
Na+ by NMDG+. Cs+ may also permeate the conduc-
tance, as indicated by the incomplete suppression of
inward currents in cells superfused with Na+-free
solutions, and the persistence of outward currents in
cells dialysed with Na+-free internal solution.
However, in order to account for the positive Erev, PNa
has to be larger than that of the other monovalent
cations present (PNa > PCs). Based on the Erev value of
+35 mV obtained in cells superfused with Cs+-free
extracellular solution and dialysed with Na+-free
pipette solution, and assuming no permeation of
NMDG+, we estimate PNa/PCs to be about 3.6. In
cardiac cells, except for HCN and TRPM4/5 chan-
nels, other non-selective channels are usually rela-
tively less permeable to Na+. HCN channels, which
display substantial Na+ permeability, are voltage-
dependent and are blocked by Cs+ in contrast to the
current described in the present study. TRPM4/5
channels are highly Na+-selective (Guinamard et al.,
2006a); however, they are activated by intracellular
Ca2+, in contrast to the conductance described in the
present study, which was present in cells dialysed
with high EDTA concentrations. The possibility
cannot be totally excluded that drugs could modify
Ca2+-dependent channels and remove the require-
ment for Ca2+i. The involvement of TRPM4/5 chan-
nels is made more unlikely by the fact that, instead
of being stimulated, they are known to be blocked
by FFA (Guinamard et al., 2006b).
The ACA-induced channel does not appear to
display marked permeability for divalent cations at
physiological concentrations as the current was not
affected by Ca2+ concentration changes, even when
effected in Na+-free solution. This lack of significant
permeability to Ca2+ makes it unlikely that the
current is due to channels with substantial PCa rela-
tive to PNa, including purinergic receptor-activated
channels (Alvarez et al., 2008) and insulin-activated
channels (Zhang and Hancox, 2003). The latter con-
ductance also shows equal PNa and PCs and can be
activated by OAG, in contrast to the conductance
described in the present study, which shows less PCs
and is not activated by OAG. TRPC6 and TRPA1,
which are activated by fenamates, as well as TRPC3
and TRPC7, which are also not inhibited and may
eventually display some activation by FFA (Jung
et al., 2002; Foster et al., 2009), are all candidates for
the current described in the present study. However,
their reported permeability profile, PCa >> PNa, is in
Figure 7
Lack of involvement of diacylglycerol or phospholipase A2. A: Lack of effect of extracellularly applied oleoyl acetyl glycerol (OAG; 100 mM) on
membrane currents measured at +80 mV and -120 mV using voltage ramps. B: Lack of effect of a-adrenoceptor (phenylephrine, PE; 40 mM) and
muscarinic (carbachol, CCh; 100 mM) agonists on the current induced by N-(p-amylcinnamoyl)anthranilic acid (ACA). C, D: Lack of effect of
extracellular application of bromoenol lactone (BEL; 25 mM; C) or bromophenacyl bromide (BPB; 50 mM; D) on membrane currents measured at
-120 mV. Periods of drug application are indicated by horizontal bars.
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apparent contrast with our findings in cardiac cells.
In addition, TRPC6 is activated by DAG and, so far,
it is uncertain whether TRPA1 is expressed in cardiac
myocytes.
The fact that the current was induced in cells
dialysed with Mg2+i concentrations known to inhibit
TRPM7 channels, suggests that these proteins were
not involved in the fenamate action. Additional fea-
tures allowing the differentiation from TRPM7
channels (Mubagwa et al., 1997; Zakharov et al.,
1999; 2003; Gwanyanya et al., 2004) include: the
substantial ACA-induced inward current in the pres-
ence of extracellular divalent cations, the insensitiv-
ity of the induced current to the removal of
extracellular divalent cations and the fact that the
current amplitude was not decreased by acidifica-
tion of the perfusing solution as observed for
TRPM7 channels (Gwanyanya et al., 2004; Jiang
et al., 2005).
Although we did not test the sensitivity of the
current to tetrodotoxin it is unlikely that the effect
of FFA and related drugs was due to a persistent
current involving voltage-dependent Na+ (NaV)
channels (Saint et al., 1992), given the linear
current–voltage relationship and the fact that
current could be obtained at potentials as
negative as -120 mV without prior activation by
depolarization.
Finally, the relationship to the background
inward Na+ current induced by muscarinic receptor
activation in cardiac myocytes, in an apparently
G-protein independent way (Matsumoto and
Pappano, 1989; Shirayama et al., 1993), is unknown.
Similar Na+-permeable conductances are activated
by neurotransmitters or peptides in a G-protein-
independent way in other cell types, including neu-
ronal (e.g. Guerineau et al., 1995) and pancreatic
cells (e.g. Rolland et al., 2002). These latter conduc-
tances are due to a tetrodotoxin-insensitive, voltage-
independent Na+ leak (also called NALCN or NaVi)
channel (Lu et al., 2007; Swayne et al., 2009).
NALCN is expressed in cardiac cells (Swayne et al.,
2009) and is therefore another candidate channel
protein underlying the current described here. In
our experiments, we failed to induce any current by
carbachol, and the agonist did not change the mag-
nitude of the current induced by ACA. Clearly, more
studies, eventually using cells from knock out
animals, are needed to identify the protein under-
lying the current described here.
Figure 8
N-(p-amylcinnamoyl)anthranilic acid (ACA) and diclofenac effects on the action potential. A, D: Superimposed action potentials recorded before
and during application of increasing concentrations of ACA (A) or of diclofenac (D). The symbol and trace colours in A and D correspond to the
column colours for the same concentrations in B and E respectively. The horizontal dashed lines indicate the 0 mV level. B, E: Action potential
duration measured at 90% repolarization (APD90) in presence of various concentrations of ACA (B) or of diclofenac (E). (*P < 0.05 for ACA vs.
control; ANOVA with post-test) C, F: Effect of 100 mM ACA (C) or 300 mM diclofenac (F) on the resting membrane potential (*P < 0.05 for ACA vs.
control). Notice the depolarization of the resting membrane and the relative lengthening of the action potential as the concentration of ACA but
not that of diclofenac is raised. Number of cells for each drug concentration indicated above the columns. Stimulation at 1 Hz.
BJP R Macianskiene et al.
426 British Journal of Pharmacology (2010) 161 416–429
Role of the novel current
Besides the molecular identity, the physiological
activators and the role of this channel remain
unknown. When activated, the channel will cause
changes in resting and action potentials. Our data
show that a depolarization of the resting mem-
brane and a lengthening of the action potential
duration are caused by ACA, which is able to
induce the new current, but not by diclofenac,
which was unable to activate the current. Using an
action potential simulation model (Clancy and
Rudy, 2002), the addition of a current similar to
the one measured in the myocytes (with Erev of
+35 mV) was also able to cause resting membrane
depolarization and action potential duration
lengthening (not illustrated). Increasing the mag-
nitude of the current many-fold compared with
the value recorded in our measurements was able
to cause early delayed afterdepolarizations. In addi-
tion to the electrophysiological effects, the current
may be implicated in intracellular Na+ and subse-
quent Ca2+ overloads associated with disease
processes.
When used clinically, FFA is reported to have a
plasma concentration of 4–12 mg·mL-1 (Aly et al.,
2000), that is, about 42 mM. Although we did not
test the effect of FFA concentrations lower than
100 mM, based on the concentration–effect curve,
the clinical concentration may be expected to cause
a small activation of the novel current. Part of the
plasma FFA may be bound to proteins, but the frac-
tion of the bound versus unbound drug is not
known. The pathophysiological relevance of the
current described here will clearly depend on
whether there are alternative mechanisms of activa-
tion via receptors or kinases.
In conclusion, the present study shows that the
fenamate FFA and related drugs induce a current
with novel characteristics in cardiac cells. The
action mechanism of these drugs remains unknown.
The novel conductance pathway is largely perme-
able to Na+, but additional studies are needed to
identify the underlying channel proteins and to
explore its physiological or pathophysiological role.
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